These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38420675)

  • 1. Liver and spleen predominantly mediate calciprotein particle clearance in a rat model of chronic kidney disease.
    Zeper LW; Bos C; Leermakers PA; Franssen GM; Raavé R; Hoenderop JGJ; de Baaij JHF
    Am J Physiol Renal Physiol; 2024 Apr; 326(4):F622-F634. PubMed ID: 38420675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients with advanced chronic kidney disease and vascular calcification have a large hydrodynamic radius of secondary calciprotein particles.
    Chen W; Anokhina V; Dieudonne G; Abramowitz MK; Kashyap R; Yan C; Wu TT; de Mesy Bentley KL; Miller BL; Bushinsky DA
    Nephrol Dial Transplant; 2019 Jun; 34(6):992-1000. PubMed ID: 29788425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of Serum Calciprotein Particle Size and Transformation Time With Arterial Calcification, Arterial Stiffness, and Mortality in Incident Hemodialysis Patients.
    Chen W; Fitzpatrick J; Monroy-Trujillo JM; Sozio SM; Jaar BG; Estrella MM; Serrano J; Anokhina V; Miller BL; Melamed ML; Bushinsky DA; Parekh RS
    Am J Kidney Dis; 2021 Mar; 77(3):346-354. PubMed ID: 32800846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic Kidney Disease Circulating Calciprotein Particles and Extracellular Vesicles Promote Vascular Calcification: A Role for GRP (Gla-Rich Protein).
    Viegas CSB; Santos L; Macedo AL; Matos AA; Silva AP; Neves PL; Staes A; Gevaert K; Morais R; Vermeer C; Schurgers L; Simes DC
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):575-587. PubMed ID: 29301790
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calciprotein particle inhibition explains magnesium-mediated protection against vascular calcification.
    Ter Braake AD; Eelderink C; Zeper LW; Pasch A; Bakker SJL; de Borst MH; Hoenderop JGJ; de Baaij JHF
    Nephrol Dial Transplant; 2020 May; 35(5):765-773. PubMed ID: 31605492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular Clearance and Biological Activity of Calciprotein Particles Depend on Their Maturation State and Crystallinity.
    Köppert S; Büscher A; Babler A; Ghallab A; Buhl EM; Latz E; Hengstler JG; Smith ER; Jahnen-Dechent W
    Front Immunol; 2018; 9():1991. PubMed ID: 30233585
    [No Abstract]   [Full Text] [Related]  

  • 7. The Role of Secondary Calciprotein Particles in the Mineralisation Paradox of Chronic Kidney Disease.
    Cai MMX; Smith ER; Tan SJ; Hewitson TD; Holt SG
    Calcif Tissue Int; 2017 Dec; 101(6):570-580. PubMed ID: 28861648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantification of Calciprotein Particles (CPPs) in Serum/Plasma Samples Using a Fluorescent Bisphosphonate.
    Miura Y; Kurosu H; Kuro-O M
    Methods Mol Biol; 2023; 2664():333-341. PubMed ID: 37423998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonate FYB-931 Prevents High Phosphate-Induced Vascular Calcification in Rat Aortic Rings by Altering the Dynamics of the Transformation of Calciprotein Particles.
    Kawakami K; Ohya M; Yashiro M; Sonou T; Yamamoto S; Nakashima Y; Yano T; Tanaka Y; Ishida K; Kobashi S; Shigematsu T; Araki SI
    Calcif Tissue Int; 2023 Aug; 113(2):216-228. PubMed ID: 37099142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calciprotein particle counts associate with vascular remodelling in chronic kidney disease.
    Feenstra L; Reijrink M; Pasch A; Smith ER; Visser LM; Bulthuis M; Lodewijk ME; Mastik MF; Greuter MJW; Slart RHJA; Mulder DJ; Pol RA; Te Velde-Keyzer CA; Krenning G; Hillebrands JL;
    Cardiovasc Res; 2024 Dec; 120(15):1953-1966. PubMed ID: 39102822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Calcium phosphate microcrystallopathy as a paradigm of chronic kidney disease progression.
    Kuro-O M
    Curr Opin Nephrol Hypertens; 2023 Jul; 32(4):344-351. PubMed ID: 37074676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Live Imaging of Calciprotein Particle Clearance and Receptor Mediated Uptake: Role of Calciprotein Monomers.
    Koeppert S; Ghallab A; Peglow S; Winkler CF; Graeber S; Büscher A; Hengstler JG; Jahnen-Dechent W
    Front Cell Dev Biol; 2021; 9():633925. PubMed ID: 33996793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of serum zinc with mineral stress in chronic kidney disease.
    Sohail A; Obereigner J; Mitter G; Schmid T; Hofer AS; Schuster G; Hügl A; Dorninger AH; Mandl M; Pasch A; Lackner HK; Papousek I; Dieplinger B; Suessner S; Antlanger M; Cejka D; Alesutan I; Voelkl J
    Clin Kidney J; 2024 Sep; 17(9):sfae258. PubMed ID: 39286240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calciprotein Particle Synthesis Strategy Determines In Vitro Calcification Potential.
    Zeper LW; Smith ER; Ter Braake AD; Tinnemans PT; de Baaij JHF; Hoenderop JGJ
    Calcif Tissue Int; 2023 Jan; 112(1):103-117. PubMed ID: 36326853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular calcification maladaptively participates in acute phosphate homeostasis.
    Turner ME; Rowsell TS; Lansing AP; Jeronimo PS; Lee LH; Svajger BA; Zelt JGE; Forster CM; Petkovich MP; Holden RM; Adams MA
    Cardiovasc Res; 2023 May; 119(4):1077-1091. PubMed ID: 36190819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clearance of fetuin-A--containing calciprotein particles is mediated by scavenger receptor-A.
    Herrmann M; Schäfer C; Heiss A; Gräber S; Kinkeldey A; Büscher A; Schmitt MM; Bornemann J; Nimmerjahn F; Herrmann M; Helming L; Gordon S; Jahnen-Dechent W
    Circ Res; 2012 Aug; 111(5):575-84. PubMed ID: 22753077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute Tissue Mineral Deposition in Response to a Phosphate Pulse in Experimental CKD.
    Zelt JG; Svajger BA; Quinn K; Turner ME; Laverty KJ; Shum B; Holden RM; Adams MA
    J Bone Miner Res; 2019 Feb; 34(2):270-281. PubMed ID: 30216554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accelerated calciprotein crystallization time (T50) is correlated with impaired lung diffusion capacity in systemic sclerosis.
    Geroldinger-Simic M; Sohail A; Razazian M; Krennmayr B; Pernsteiner V; Putz T; Lackner HK; Pasch A; Sepp N; Alesutan I; Voelkl J
    Front Immunol; 2024; 15():1425885. PubMed ID: 39399492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A study on biorelevant calciprotein particles: Effect of stabilizing agents on the formation and crystallization mechanisms.
    Gelli R; Pucci V; Ridi F; Baglioni P
    J Colloid Interface Sci; 2022 Aug; 620():431-441. PubMed ID: 35439694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnesium and calciprotein particles in vascular calcification: the good cop and the bad cop.
    Zeper LW; de Baaij JHF
    Curr Opin Nephrol Hypertens; 2019 Jul; 28(4):368-374. PubMed ID: 31045659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.